Legal & General Group PLC Monte Rosa Therapeutics, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 4,245 shares of GLUE stock, worth $60,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,245

Previous 4,245 -0.0%

Holding current value

$60,958

Previous $19,000 63.16%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$3.7 - $5.33 $2,397 - $3,453	648 Added 18.02%	4,245 $19,000
Q4 2024 Feb 13, 2025	SELL	$4.8 - $10.36 $62,217 - $134,286	-12,962 Reduced 78.28%	3,597 $24,000
Q3 2024 Feb 28, 2025	BUY	$3.59 - $6.97 $46,533 - $90,345	12,962 Added 360.36%	16,559 $87,000
Q3 2024 Nov 14, 2024	BUY	$3.59 - $6.97 $2,714 - $5,269	756 Added 4.78%	16,559 $87,000
Q1 2024 May 29, 2025	BUY	$4.26 - $8.46 $51,997 - $103,262	12,206 Added 339.34%	15,803 $111,000

Q1 2024 May 14, 2024	SELL	$4.26 - $8.46 $18,594 - $36,927	-4,365 Reduced 21.64%	15,803 $111,000
Q4 2023 May 29, 2025	BUY	$2.5 - $5.93 $41,427 - $98,266	16,571 Added 460.69%	20,168 $113,000
Q4 2023 Feb 15, 2024	SELL	$2.5 - $5.93 $36,142 - $85,730	-14,457 Reduced 41.75%	20,168 $113,000
Q3 2023 Nov 14, 2023	BUY	$4.78 - $7.22 $30,921 - $46,706	6,469 Added 22.98%	34,625 $165,000
Q2 2023 Aug 14, 2023	BUY	$4.53 - $8.4 $90,314 - $167,470	19,937 Added 242.57%	28,156 $192,000
Q1 2023 May 15, 2023	BUY	$5.95 - $8.21 $4,646 - $6,412	781 Added 10.5%	8,219 $64,000
Q4 2022 Feb 14, 2023	BUY	$6.71 - $9.72 $2,576 - $3,732	384 Added 5.44%	7,438 $56,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $932 - $1,580	130 Added 1.88%	7,054 $57,000
Q2 2022 Aug 22, 2022	BUY	$6.15 - $14.99 $11,875 - $28,945	1,931 Added 38.67%	6,924 $67,000
Q1 2022 May 16, 2022	BUY	$10.36 - $20.41 $17,363 - $34,207	1,676 Added 50.53%	4,993 $70,000
Q4 2021 Feb 14, 2022	BUY	$16.28 - $27.15 $36,385 - $60,680	2,235 Added 206.56%	3,317 $68,000
Q3 2021 Nov 15, 2021	SELL	$18.59 - $42.21 $35,655 - $80,958	-1,918 Reduced 63.93%	1,082 $24,000
Q2 2021 Aug 12, 2021	BUY	$18.86 - $22.7 $56,580 - $68,100	3,000 New	3,000 $69,000

Others Institutions Holding GLUE

# of Institutions

133

Shares Held

55.7M

Call Options Held

159K

Put Options Held

269K

View Full List

About Monte Rosa Therapeutics, Inc.

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $671M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

More about GLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Monte Rosa Therapeutics, Inc. Transaction History